CERUSO, MARIANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.820
EU - Europa 1.118
AS - Asia 324
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.273
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.815
RU - Federazione Russa 519
IE - Irlanda 194
IT - Italia 168
SG - Singapore 124
SE - Svezia 86
CN - Cina 79
HK - Hong Kong 73
FI - Finlandia 54
PL - Polonia 32
ES - Italia 30
IN - India 30
GB - Regno Unito 16
CI - Costa d'Avorio 10
UA - Ucraina 7
JO - Giordania 6
CA - Canada 5
DE - Germania 5
CH - Svizzera 4
VN - Vietnam 4
PK - Pakistan 3
TR - Turchia 3
DK - Danimarca 1
EU - Europa 1
FR - Francia 1
NL - Olanda 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 6.273
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.329
Fairfield 766
Woodbridge 349
Seattle 318
Ashburn 300
Houston 290
Cambridge 275
Wilmington 212
Dublin 194
Chandler 153
Princeton 122
Altamura 110
Singapore 102
Lawrence 97
Ann Arbor 95
Boston 35
Warsaw 32
Barcelona 30
Medford 29
Kent 26
Florence 25
Hong Kong 24
Mumbai 23
San Diego 22
Shanghai 21
Falls Church 16
Boardman 15
Beijing 12
Abidjan 10
Gavirate 10
Moscow 10
Norwalk 9
New York 8
Hillsboro 7
London 7
Laurel 6
Rome 6
Andover 5
Guangzhou 5
Toronto 5
Bern 4
Los Angeles 4
Acton 3
Buffalo 3
Detroit 3
Lahore 3
Misano Adriatico 3
Redmond 3
Yaroslavl 3
Yubileyny 3
Castelliri 2
Dong Ket 2
Felino 2
Fuzhou 2
Redwood City 2
Rui'an 2
Washington 2
Wuhan 2
Bari 1
Bremen 1
Cagliari 1
Dongyang 1
Elmendorf 1
Groningen 1
Hangzhou 1
Helsinki 1
Jacksonville 1
Jiaxing 1
Jiujiang 1
New Bedfont 1
Prescot 1
Riyadh 1
San Jose 1
San Mateo 1
Selargius 1
Serra 1
Shenzhen 1
Tashkent 1
Teramo 1
Xuzhou 1
Totale 5.180
Salva come PNG Salva come JPEG
Nome #
Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties 157
4-Arylbenzenesulfonamides as Human Carbonic Anhydrase Inhibitors (hCAIs): Synthesis by Pd Nanocatalyst-Mediated Suzuki-Miyaura Reaction, Enzyme Inhibition, and X-ray Crystallographic Studies 147
Design and validation of FRESH, a drug discovery paradigm resting on robust chemical synthesis 143
Geographical characterization by MAE-HPLC and NIR methodologies and carbonic anhydrase inhibition of Saffron components 142
Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium 138
Aryl-4,5-dihydro-1H-pyrazole-1-carboxamide derivatives bearing a sulfonamide moiety show single-digit nanomolar-to-subnanomolar inhibition constants against the tumor-associated human carbonic anhydrases IX and XII 137
Discovery of β-Adrenergic Receptors Blocker-Carbonic Anhydrase Inhibitor Hybrids for Multitargeted Antiglaucoma Therapy 135
Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII 134
Design, synthesis and evaluation of N-substituted saccharin derivatives as selective inhibitors of tumor-associated carbonic anhydrase XII 133
New natural product carbonic anhydrase inhibitors incorporating phenol moieties 131
Amido/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII 131
Benzenesulfonamides Incorporating Flexible Triazole Moieties Are Highly Effective Carbonic Anhydrase Inhibitors: Synthesis and Kinetic, Crystallographic, Computational, and Intraocular Pressure Lowering Investigations 130
Pyrazolylbenzo[d]imidazoles as new potent and selective inhibitors of carbonic anhydrase isoforms hCA IX and XII 129
Cyclic tertiary sulfamates: Selective inhibition of the tumor-associated carbonic anhydrases IX and XII by N- and O-substituted acesulfame derivatives 129
7-Aryl-triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrase IX and XII 129
New series of sulfonamides containing amino acid moiety act as effective and selective inhibitors of tumor-associated carbonic anhydrase XII 128
Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms 127
Carbonic anhydrase inhibitory activity of sulfonamides and carboxylic acids incorporating cyclic imide scaffolds 122
A novel library of saccharin and acesulfame derivatives as potent and selective inhibitors of carbonic anhydrase IX and XII isoforms 122
Development of 3-(4-aminosulphonyl)-phenyl-2-mercapto-3H-quinazolin-4-ones as inhibitors of carbonic anhydrase isoforms involved in tumorigenesis and glaucoma 120
Synthesis of 4-sulfamoylphenyl-benzylamine derivatives with inhibitory activity against human carbonic anhydrase isoforms I, II, IX and XII 120
Open saccharin-based secondary sulfonamides as potent and selective inhibitors of cancer-related carbonic anhydrase IX and XII isoforms 117
Inhibition studies of new ureido-substituted sulfonamides incorporating a GABA moiety against human carbonic anhydrase isoforms I-XIV. 116
Synthesis 4-[2-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-ethyl]-benzenesulfonamides with subnanomolar carbonic anhydrase II and XII inhibitory properties 116
New 4-[(3-cyclohexyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzene-1-sulfonamides, synthesis and inhibitory activity toward carbonic anhydrase I, II, IX, XII 115
Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII 115
Carbonic anhydrase inhibitors: Design, synthesis, and biological evaluation of novel sulfonyl semicarbazide derivatives 114
Structure–Activity Relationships of Benzenesulfonamide-Based Inhibitors towards Carbonic Anhydrase Isoform Specificity 112
4-Functionalized 1,3-diarylpyrazoles bearing 6-aminosulfonylbenzothiazole moiety as potent inhibitors of carbonic anhydrase isoforms hCA I, II, IX and XII 108
Inhibition of carbonic anhydrase isoforms I, II, IV, VII and XII with carboxylates and sulfonamides incorporating phthalimide/phthalic anhydride scaffolds 108
Selective inhibition of human carbonic anhydrases by novel amide derivatives of probenecid: Synthesis, biological evaluation and molecular modelling studies 107
Inhibition studies of quinazoline-sulfonamide derivatives against the γ-CA (PgiCA) from the pathogenic bacterium, Porphyromonas gingivalis 107
Design and synthesis of benzothiazole-6-sulfonamides acting as highly potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII 106
Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives 106
Arylamino bisphosphonates: Potent and selective inhibitors of the tumor-associated carbonic anhydrase XII 106
Synthesis of Schiff base derivatives of 4-(2-aminoethyl)-benzenesulfonamide with inhibitory activity against carbonic anhydrase isoforms I, II, IX and XII 105
Sulfamide derivatives with selective carbonic anhydrase VII inhibitory action 105
Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: Identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones 104
Sulfonamide bearing pyrazolylpyrazolines as potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII 103
Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors 102
Quinazoline-sulfonamides with potent inhibitory activity against the α-carbonic anhydrase from Vibrio cholerae 102
New approaches to the synthesis of sildenafil analogues and their enzyme inhibitory activity 101
Inhibition studies of Brucella suis β-carbonic anhydrases with a series of 4-substituted pyridine-3-sulphonamides 98
Novel sulfonamides bearing pyrrole and pyrrolopyrimidine moieties as carbonic anhydrase inhibitors: Synthesis, cytotoxic activity and molecular modeling 98
Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors 97
Sulfonamides incorporating fluorine and 1,3,5-triazine moieties are effective inhibitors of three β-class carbonic anhydrases from Mycobacterium tuberculosis. 96
Pyrazolo[4,3-e][1,2,4]triazine sulfonamides as carbonic anhydrase inhibitors with antitumor activity 96
Synthesis of sulfonamides with effective inhibitory action against Porphyromonas gingivalis γ-carbonic anhydrase. 95
Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties 93
New pyrazolo[4,3-e][1,2,4]triazine sulfonamides as carbonic anhydrase inhibitors 89
Exploring new Probenecid-based carbonic anhydrase inhibitors: Synthesis, biological evaluation and docking studies 89
A new class of quinazoline-sulfonamides acting as efficient inhibitors against the α-carbonic anhydrase from Trypanosoma cruzi 88
New amide derivatives of Probenecid as selective inhibitors of carbonic anhydrase IX and XII: Biological evaluation and molecular modelling studies 87
Inhibition studies of bacterial, fungal and protozoan β-class carbonic anhydrases with Schiff bases incorporating sulfonamide moieties 86
Inhibition of carbonic anhydrase isoforms I, II, IX and XII with Schiff’s bases incorporating iminoureido moieties 66
Sulfonamides with potent inhibitory action and selectivity against the α-carbonic anhydrase from Vibrio cholerae 66
5-Arylisothiazol-3(2H)-one-1,(1)-(di)oxides: A new class of selective tumor-associated carbonic anhydrases (hCA IX and XII) inhibitors 47
Totale 6.350
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.203
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.203
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020931 0 0 0 0 0 204 189 181 179 82 56 40
2020/2021562 44 58 44 58 26 32 9 43 55 118 48 27
2021/2022343 14 4 43 10 6 24 9 35 16 23 34 125
2022/2023876 153 241 47 48 40 127 118 30 44 3 18 7
2023/2024212 9 24 61 9 19 11 4 29 2 8 28 8
2024/20252.195 112 227 108 284 1.099 365 0 0 0 0 0 0
Totale 6.350